RyMed Technologies Wins Patent Infringement Case Against ICU Medical

A federal jury has found in favor of RyMed Technologies and against ICU Medical

in a closely-watched patent infringement case. The jury ruled that RyMed's InVision-Plus® with Neutral AdvantageTM technology products do not infringe on a patent held by ICU Medical. The unanimous ruling by an eight-person jury means that ICU Medical can no longer make any claim that RyMed's products literally infringe on an in-force ICU Medical patent, said Dana Wm. Ryan, President, CEO and Chairman of the Board of RyMed Technologies.